* Estimate of GFR based on a Modification of Diet in Renal Disease (MDRD) equation. * For a total treatment duration of 5 to 14 days for the treatment of ABSSSI and 5 to 10 days for the treatment of CABP. * All intravenous doses of BAXDELA are administered over 60 minutes. * Not recommended due to insufficient information to provide dosing recommendations.
Oral
Intravenous ‡
30-89
No dosage adjustment
No dosage adjustment
15-29
No dosage adjustment
200 mg every 12 hours
End Stage Renal Disease (ESRD) (< 15 including hemodialysis)
Not Recommended §
Get Your Patient on Baxdela
See your patient's specific prior authorization requirements including coverage restrictions and step therapies